Dr. William Helton, MD – Seattle, WA
Does mesenteric venous imaging assessment accurately predict pathologic invasion in localized pancreatic ductal adenocarcinoma?
Clanton J, Oh S, Kaplan SJ, Johnson E, Ross A, Kozarek R, Alseidi A, Biehl T, Picozzi VJ, Helton WS, Coy D, Dorer R, Rocha FG, HPB (Oxford), 1/9/2018Gemcitabine and Taxane Adjuvant Therapy with Chemoradiation in Resected Pancreatic Cancer: A Novel Strategy for Improved Survival?
Kanji ZS, Edwards AM, Mandelson MT, Sahar N, Lin BS, Badiozamani K, Song G, Alseidi A, Biehl TR, Kozarek RA, Helton WS, Picozzi VJ, Rocha FG, Ann Surg Oncol, 1/1/2018Localized pancreatic cancer with positive peritoneal cytology as a sole manifestation of metastatic disease: a single-institution experience
Oh SY, Edwards A, Mandelson MT, Hahn H, Alseidi A, Biehl T, Kozarek RA, Rocha FG, Helton S, Picozzi VJ, Am J Surg, 1/1/2017
